Antidepressants and type 2 diabetes link found in young people
Children and teenagers who take antidepressants are at a greater risk of developing type 2 diabetes, research has suggested. US study findings of nearly just…
Medications & Treatments
Oral semaglutide shows positive results compared to injectable version
Oral semaglutide has been shown to reduce blood sugar levels and hypoglycemia in people with type 2 diabetes at a similar rate to injectable semaglutide.…
Good blood sugar balance may help lower risk of heart failure in type 2 diabetes
A new study suggests that keeping blood sugars balanced while adapting drug treatments could help lower the incidence of heart failure among people with type…
Refusing Insulin Therapy
It’s a familiar refrain among many people with Type 2 diabetes, with varying wording but an idea that remains constant: “I hope I don’t have…
Insulin pump treatment shown to outperform injections in children with type 1 diabetes
Youngsters with type 1 diabetes who use insulin pumps had better blood sugar control than children who injected insulin, a new study reveals. Insulin pump…
Early antibiotics use not associated with type 1 diabetes or celiac disease, study suggests
Antibiotic use in very early childhood is not associated with the development of type 1 diabetes or celiac disease, according to new research. Scientists at…
Preventing Fatty Liver Disease (NAFLD)
When was the last time you had a chat with your doctor about your liver? Can’t remember? Maybe never? Well, it’s probably time to do…
Folate-producing probiotics may help with gastrointestinal side effects of metformin
New research suggest that specific probiotics formulated to stimulate the production of folate (also know as vitamin B9) in the colon might help alleviate metformin-associated…
GLP-1 receptor agonists have benefits for insulin-treated type 2 diabetes
Taking a glucagon-like peptide 1 (GLP-1) receptor agonist can help people who struggle to control their type 2 diabetes using insulin achieve better blood sugar…
Johnson and Johnson to exit insulin pump business
The Johnson &Johnson diabetes care unit Animas Corp is planning to close operations and exit the insulin pump business. Animas, the second-largest manufacturer of insulin…